<DOC>
	<DOCNO>NCT01132612</DOCNO>
	<brief_summary>The purpose study provide long term clinical data compound treatment indication moderate severe chronic plaque-type psoriasis .</brief_summary>
	<brief_title>AIN457 Regimen Finding Extension Study Patients With Moderate Severe Psoriasis</brief_title>
	<detailed_description>The purpose study provide long term clinical data compound treatment indication moderate severe chronic plaque-type psoriasis . In Proof-of-Concept study ( CAIN457A2102 ) , AIN457 proven efficacious treatment moderate severe chronic plaque-type psoriasis . As result , phase IIb regimen find study start ( CAIN457A2211 ) . The data gather extension study core study ( CAIN457A2211 ) use expand safety database compound treatment moderate severe chronic plaque-type psoriasis . The patient extension study continue stay exact treatment regimen take complete core study .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Patients complete core study CAIN457A2211 . A patient define complete core study he/she complete study include visit 13 ( F4 ) core study Patients must able understand communicate investigator comply requirement study must give write , sign date informed consent study assessment perform . Patients must expect benefit ongoing treatment AIN457 , assess patient investigator Male patient must consent practice reliable contraception study 16 week last dose study drug administration Patients experience second consecutive full relapse visit 13 ( week F4 ) core study CAIN457A2211 Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test ( &gt; 5mlU/mL ) Women childbearing potential , defined woman physiologically capable become pregnant , UNLESS : woman whose career , lifestyle , sexual orientation precludes intercourse male partner woman whose partner sterilize vasectomy mean use highly effective method birth control ( i.e . one result less 1 % per year failure rate use consistently correctly , implant , injectables , combine oral contraceptive , condom ( partner ) intrauterine device ( IUDs ) ; Periodic abstinence ( e.g . calendar , ovulation , symptothermal , postovulation method ) acceptable Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Chronic plaque-type psoriasis</keyword>
	<keyword>AIN457</keyword>
	<keyword>dermatology</keyword>
	<keyword>Moderate severe chronic plaque-type psoriasis</keyword>
</DOC>